Published in Cancer Weekly, October 22nd, 2002
In a prospective multicenter study, the scientists, led by M. Maynadie, "examined and quantified the expression of the three classes of CD34 on fresh leukemic blast cells from 300 cases of acute myeloid leukemia (AML). The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.